title: [Miliary tuberculosis as a complication of BCG immunotherapy in cancer of the bladder. Case report].
abstract: Intravesical administration of BCG may be used as an ancillary immunotherapy after endoscopic resection for cancer of the bladder. Local side effects are usually mild. Here is reported a patient who developed miliary tuberculosis after this form of therapy. Radiologic studies of the thorax and liver biopsy confirmed the diagnosis. The patient recovered after treatment with anti-tuberculosis drugs (TA-81 scheme). Epithelial trauma may be invoked as an alteration facilitating this complication. Although it develops infrequently, patients with bladder cancer treated with BCG must be monitored for this complication.
authors.affiliation: Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica, Santiago de Chile.
authors.forename: M
authors.initials: M
authors.lastname: Arrese
authors.forename: L
authors.initials: L
authors.lastname: Ebel
authors.forename: E
authors.initials: E
authors.lastname: Hofmann
authors.forename: P
authors.initials: P
authors.lastname: Gaete
authors.forename: A
authors.initials: A
authors.lastname: Jara
authors.forename: K
authors.initials: K
authors.lastname: Cabrera
authors.forename: F
authors.initials: F
authors.lastname: Araos
authors.forename: P
authors.initials: P
authors.lastname: Del Río
authors.forename: V
authors.initials: V
authors.lastname: Valdivieso
mesh_terms: D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D014391:Tuberculosis, Miliary / Q000175:diagnosis / Q000209:etiology*; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D001500:BCG Vaccine
vernacular_title: Tuberculosis miliar como complicacion de inmunoterapia con BCG en el cancer de vejiga. Caso clinico.